Close Menu

The New York Times reports on concerns in the biomedical community about what to do as our ability to detect tumors improves -- to the point where even the slightest number of cancerous cells will send up the alarm. As genomic tests advance, sensitivity will only increase -- but what does that mean for patients who may be treated for cancer when really they're quite healthy? From the article:

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The World Health Organization will be providing low-cost COVID-19 tests to low- and middle-income nations, according to Reuters.

Nature News examines how the confirmation of Amy Coney Barrett to the US Supreme Court could affect scientific agencies.

Nobel Prize-winner Arthur Ashkin, who developed optical tweezers, has died at 98, the Washington Post reports.

In PNAS this week: altered gene expression in brain samples from Alzheimer's disease patients, effects of gene mutations found in bladder cancer, and more.